BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 228.00
+0.20 (0.09%)
Aug 21, 2026, 4:08 PM HKT
BeOne Medicines AG Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 5,098 | 4,548 | 2,627 | 3,172 | 3,870 | 4,376 |
Short-Term Investments | - | - | - | - | 665.25 | 2,245 |
Cash & Short-Term Investments | 5,098 | 4,548 | 2,627 | 3,172 | 4,535 | 6,621 |
Cash Growth | 84.98% | 73.08% | -17.16% | -30.06% | -31.50% | 42.36% |
Accounts Receivable | 1,056 | 865.08 | 676.28 | 358.03 | 173.17 | 483.11 |
Other Receivables | 14.78 | 21.78 | 32.83 | 37.86 | 25.82 | 17.06 |
Receivables | 1,071 | 886.86 | 709.11 | 395.89 | 198.98 | 500.18 |
Inventory | 732.6 | 608.23 | 494.99 | 416.12 | 282.35 | 242.63 |
Prepaid Expenses | 34.37 | 55.93 | 49.37 | 88.26 | 83.09 | 138.81 |
Restricted Cash | 161.05 | 41.28 | 9.31 | 11.47 | 0.2 | 0.33 |
Other Current Assets | 118.79 | 93.76 | 101.41 | 119.88 | 107.65 | 111.32 |
Total Current Assets | 7,216 | 6,234 | 3,992 | 4,203 | 5,207 | 7,614 |
Property, Plant & Equipment | 1,789 | 1,790 | 1,718 | 1,419 | 955.91 | 705.04 |
Long-Term Investments | 66.06 | 61.68 | 128.93 | 89.64 | 91.78 | 100.79 |
Goodwill | - | - | - | - | - | 0.11 |
Other Intangible Assets | 60.96 | 62.7 | 51.1 | 57.14 | 40.62 | 46.68 |
Other Long-Term Assets | 43.53 | 40.74 | 31.56 | 35.72 | 83.91 | 69.03 |
Total Assets | 9,176 | 8,189 | 5,921 | 5,805 | 6,379 | 8,536 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 470.3 | 479.04 | 405 | 315.11 | 294.78 | 262.4 |
Accrued Expenses | 948.76 | 961.09 | 780.48 | 624.92 | 480.1 | 534.33 |
Short-Term Debt | 130.13 | 9.06 | 816.95 | 659.79 | 314.83 | 424.74 |
Current Portion of Long-Term Debt | 150.04 | 104.94 | 34.58 | 28.58 | 14.14 | 2.82 |
Current Portion of Leases | 21.95 | 20.7 | 17.58 | 21.95 | 24.04 | 21.93 |
Current Income Taxes Payable | 76.32 | 41.63 | 25.93 | 22.95 | 25.19 | 21.4 |
Current Unearned Revenue | - | - | - | - | 213.86 | 187.41 |
Other Current Liabilities | 321.68 | 212.37 | 134.39 | 136.82 | 101.59 | 144.53 |
Total Current Liabilities | 2,119 | 1,829 | 2,215 | 1,810 | 1,469 | 1,600 |
Long-Term Debt | 1,699 | 1,812 | 166.48 | 197.62 | 209.15 | 202.11 |
Long-Term Leases | 48.2 | 52.94 | 44.28 | 22.25 | 34.52 | 43.04 |
Long-Term Unearned Revenue | 28.46 | 28.98 | 30.32 | 34.2 | 80.2 | 266.64 |
Pension & Post-Retirement Benefits | 17.76 | 18.17 | 16.41 | 15 | 7.76 | 7.81 |
Long-Term Deferred Tax Liabilities | 57.39 | 53.21 | 42.01 | 16.49 | 16 | 14.17 |
Other Long-Term Liabilities | 31.43 | 33.1 | 74.29 | 172.27 | 179.78 | 269.63 |
Total Liabilities | 4,002 | 3,827 | 2,589 | 2,268 | 1,996 | 2,403 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.15 | 0.14 | 0.14 | 0.14 | 0.14 | 0.13 |
Additional Paid-In Capital | 13,055 | 12,759 | 12,088 | 11,599 | 11,541 | 11,191 |
Retained Earnings | -7,856 | -8,320 | -8,607 | -7,962 | -7,080 | -5,077 |
Comprehensive Income & Other | -25.37 | -78.18 | -148.99 | -99.45 | -77.42 | 17.95 |
Total Common Equity | 5,174 | 4,361 | 3,332 | 3,537 | 4,383 | 6,133 |
Shareholders' Equity | 5,174 | 4,361 | 3,332 | 3,537 | 4,383 | 6,133 |
Total Liabilities & Equity | 9,176 | 8,189 | 5,921 | 5,805 | 6,379 | 8,536 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2,050 | 2,000 | 1,080 | 930.19 | 596.68 | 694.64 |
Net Cash (Debt) | 3,049 | 2,548 | 1,548 | 2,242 | 3,938 | 5,926 |
Net Cash Growth | 76.18% | 64.63% | -30.96% | -43.08% | -33.54% | 44.94% |
Net Cash Per Share | 26.41 | 22.46 | 14.70 | 21.47 | 38.19 | 63.87 |
Filing Date Shares Outstanding | 113.7 | 110.94 | 106.72 | 104.58 | 104.32 | 102.68 |
Total Common Shares Outstanding | 113.02 | 110.85 | 106.72 | 104.58 | 104.32 | 102.68 |
Working Capital | 5,097 | 4,405 | 1,777 | 2,393 | 3,739 | 6,014 |
Book Value Per Share | 45.78 | 39.34 | 31.22 | 33.82 | 42.02 | 59.73 |
Tangible Book Value | 5,113 | 4,298 | 3,281 | 3,480 | 4,343 | 6,086 |
Tangible Book Value Per Share | 45.24 | 38.78 | 30.75 | 33.28 | 41.63 | 59.27 |
Land | 71.43 | 71.43 | 65.49 | 65.49 | 65.49 | 65.49 |
Buildings | 1,205 | 1,188 | 607.86 | 231.66 | 222.45 | 144.08 |
Machinery | 617.88 | 583.24 | 485.14 | 392.21 | 334.59 | 237.79 |
Construction In Progress | 152.67 | 127.16 | 654.02 | 740.62 | 293.63 | 186.84 |
Leasehold Improvements | 79.53 | 76.57 | 64.68 | 60.12 | 53.79 | 50.29 |